Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Genomics Proteomics 40, 100888
This process matters because your liver handles everything from medication byproducts and alcohol to metabolic waste and environmental exposures
Thm vo , Glutathione gip trung ha cc gc t do, h tr lm chm qu trnh lo ha t nhin cng nh lo ha do tc ng mi trng, gip chng ta trng tr trung, y sc sng
In contrast, His exists in both protonated and deprotonated states at physiological pH, so it can readily gain a proton and act as a general base in reactions
Multivitamin/mineral Supplements - Fact Sheet for Consumers